Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Ophthalmology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

etanercept

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of etanercept

104 trials tracked of etanercept: 59 in phase 3 or 4 and 15 with published results. The most-cited published study has 388 citations.

104Trials tracked

59Phase 3 & 4

0Recruiting

15With published results

Phase distribution

Phase 4 34 Phase 3 25 Phase 2 16 Phase 1 3 Other / NA 26

Phase 3 Etanercept (Enbrel®) in Psoriasis - Pediatrics Completed · 388 cited
Phase 4 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Completed · 234 cited
Phase 3 Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Completed · 216 cited
Phase 3 Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) Completed · 131 cited
Phase 3 A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs Completed · 108 cited
Phase 3 TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial Completed · 102 cited

Show 44 more trials

Phase 3 Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Completed · 92 cited
Phase 4 Treatments Against RA and Effect on FDG-PET/CT Completed · 74 cited
Phase 3 Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis Completed · 47 cited
Phase 3 Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Completed · 43 cited
Phase 4 Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening Completed · 37 cited
Phase 4 Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis Completed · 15 cited
Phase 4 Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast Completed · 7 cited
Phase 4 Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA Completed · 6 cited
Phase 3 Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects Completed · 1 cited
Phase 4 Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis Completed
Phase 4 The Immunological Basis for Treatment Resistance to Anti-TNF Treatments Completed
Phase 4 Anti-inflammatory Therapy to Improve Outcomes After TPIAT Completed
Phase 4 Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients Completed
Phase 4 Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis Completed
Phase 4 Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain Completed
Phase 4 Anti-TNF Agents for the Treatment of Rheumatoid Arthritis Completed
Phase 4 Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis Completed
Phase 4 Can We Miss Pigmented Lesions in Psoriasis Patients? Completed
Phase 4 Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis Completed
Phase 4 REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) Completed
Phase 4 Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis Completed
Phase 4 Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) Completed
Phase 4 Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis Completed
Phase 4 Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA Completed
Phase 4 Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis Completed
Phase 4 Safety and Efficacy of Combining nbUVB to Etanercept in Patients Completed
Phase 4 Moderate to Severe Plaque Psoriasis With Scalp Involvement Completed
Phase 4 Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy Completed
Phase 4 Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis Completed
Phase 4 CAMEO: Canadian Methotrexate and Etanercept Outcome Study Completed
Phase 4 Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept Completed
Phase 4 Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) Completed
Phase 4 Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis Completed
Phase 4 A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis Completed
Phase 4 Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis Completed
Phase 4 Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy Completed
Phase 4 Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis Completed
Phase 3 Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis Completed
Phase 3 Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Completed
Phase 3 Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) Completed
Phase 3 Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) Completed
Phase 3 Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis Completed
Phase 3 A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis Completed
Phase 3 Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA Completed

Showing the 50 most-cited and recently-updated of 104 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.